Loading
Latest filing published 08 Feb 2016 for ALBANY MOLECULAR RESEARCH INC. Read the official filing
No signal scores available.
Anthony J. Maddaluna has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Albany Molecular Research Inc and Pfizer Inc. We count 2 filings; the first trade dates from 1 February 2016 and the latest from 4 February 2016.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 8 February 2016 with a share grant in Albany Molecular Research Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations